TY - JOUR
T1 - Increased Cardiac Risk After a Second Malignant Neoplasm Among Childhood Cancer Survivors
T2 - A FCCSS Study
AU - Charrier, Thibaud
AU - Haddy, Nadia
AU - Schwartz, Boris
AU - Journy, Neige
AU - Fresneau, Brice
AU - Demoor-Goldschmidt, Charlotte
AU - Diallo, Ibrahima
AU - Surun, Aurore
AU - Aerts, Isabelle
AU - Doz, François
AU - Souchard, Vincent
AU - Vu-Bezin, Giao
AU - Laprie, Anne
AU - Lemler, Sarah
AU - Letort, Véronique
AU - Rubino, Carole
AU - Chounta, Stéfania
AU - de Vathaire, Florent
AU - Latouche, Aurélien
AU - Allodji, Rodrigue S.
N1 - Publisher Copyright:
© 2023 The Authors
PY - 2023/12/1
Y1 - 2023/12/1
N2 - Background: Childhood cancer survivors (CCS) are at an elevated risk of developing both a second malignant neoplasm (SMN) and cardiac disease. Objectives: This study sought to assess the excess of occurrence of cardiac disease after a SMN among CCS. Methods: Analyses included 7,670 CCS from the French Childhood Cancer Survivors Study cohort diagnosed between 1945 and 2000. To account for the time dependence of the occurrence of a SMN, we employed a landmark approach, considering an additive regression model for the cumulative incidence of cardiac disease. We estimated the effect of a SMN on the instantaneous risk of cardiac disease using a proportional cause-specific hazard model, considering a SMN as a time-dependent exposure. In both models, we adjusted for demographic and treatment information and considered death as a competing event. Results: In 7,670 CCS over a median follow-up of 30 years (IQR: 22-38 years), there were 378 cases of cardiac disease identified, of which 49 patients experienced a SMN. Patients who survived 25 years after their childhood cancer diagnosis and had a SMN in that time frame had a significantly increased cumulative incidence of cardiac disease, which was 3.8% (95% CI: 0.5% to 7.1%) higher compared with those without a SMN during this period. No SMN-induced excess of cardiac disease was observed at subsequent landmark times. SMNs were associated with a 2-fold increase (cause-specific HR: 2.0; 95% CI: 1.4-2.8) of cardiac disease. Conclusions: The occurrence of a SMN among CCS is associated with an increased risk of cardiac disease occurrence and risk at younger ages.
AB - Background: Childhood cancer survivors (CCS) are at an elevated risk of developing both a second malignant neoplasm (SMN) and cardiac disease. Objectives: This study sought to assess the excess of occurrence of cardiac disease after a SMN among CCS. Methods: Analyses included 7,670 CCS from the French Childhood Cancer Survivors Study cohort diagnosed between 1945 and 2000. To account for the time dependence of the occurrence of a SMN, we employed a landmark approach, considering an additive regression model for the cumulative incidence of cardiac disease. We estimated the effect of a SMN on the instantaneous risk of cardiac disease using a proportional cause-specific hazard model, considering a SMN as a time-dependent exposure. In both models, we adjusted for demographic and treatment information and considered death as a competing event. Results: In 7,670 CCS over a median follow-up of 30 years (IQR: 22-38 years), there were 378 cases of cardiac disease identified, of which 49 patients experienced a SMN. Patients who survived 25 years after their childhood cancer diagnosis and had a SMN in that time frame had a significantly increased cumulative incidence of cardiac disease, which was 3.8% (95% CI: 0.5% to 7.1%) higher compared with those without a SMN during this period. No SMN-induced excess of cardiac disease was observed at subsequent landmark times. SMNs were associated with a 2-fold increase (cause-specific HR: 2.0; 95% CI: 1.4-2.8) of cardiac disease. Conclusions: The occurrence of a SMN among CCS is associated with an increased risk of cardiac disease occurrence and risk at younger ages.
KW - additive model, anthracycline chemotherapy, cardiac disease
KW - cardio-oncology
KW - cumulative incidence
KW - late effect, radiation
UR - http://www.scopus.com/inward/record.url?scp=85174466179&partnerID=8YFLogxK
U2 - 10.1016/j.jaccao.2023.07.008
DO - 10.1016/j.jaccao.2023.07.008
M3 - Article
AN - SCOPUS:85174466179
SN - 2666-0873
VL - 5
SP - 792
EP - 803
JO - JACC: CardioOncology
JF - JACC: CardioOncology
IS - 6
ER -